These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 28389557)

  • 1. Glucuronides in the gut: Sugar-driven symbioses between microbe and host.
    Pellock SJ; Redinbo MR
    J Biol Chem; 2017 May; 292(21):8569-8576. PubMed ID: 28389557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the metabolic effects of the selective inhibition of gut microbial β-glucuronidases in mice.
    Letertre MPM; Bhatt AP; Harvey M; Nicholson JK; Wilson ID; Redinbo MR; Swann JR
    Sci Rep; 2022 Oct; 12(1):17435. PubMed ID: 36261446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics.
    Simpson JB; Walker ME; Sekela JJ; Ivey SM; Jariwala PB; Storch CM; Kowalewski ME; Graboski AL; Lietzan AD; Walton WG; Davis KA; Cloer EW; Borlandelli V; Hsiao YC; Roberts LR; Perlman DH; Liang X; Overkleeft HS; Bhatt AP; Lu K; Redinbo MR
    Cell Host Microbe; 2024 Jun; 32(6):925-944.e10. PubMed ID: 38754417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gut Microbiota Impact Cancer Etiology through "Phase IV Metabolism" of Xenobiotics and Endobiotics.
    Ervin SM; Redinbo MR
    Cancer Prev Res (Phila); 2020 Aug; 13(8):635-642. PubMed ID: 32611614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10.
    Wei B; Wang PP; Yan ZX; Yan R
    Appl Microbiol Biotechnol; 2018 Nov; 102(21):9193-9205. PubMed ID: 30109395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens.
    Ervin SM; Li H; Lim L; Roberts LR; Liang X; Mani S; Redinbo MR
    J Biol Chem; 2019 Dec; 294(49):18586-18599. PubMed ID: 31636122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling.
    Jariwala PB; Pellock SJ; Goldfarb D; Cloer EW; Artola M; Simpson JB; Bhatt AP; Walton WG; Roberts LR; Major MB; Davies GJ; Overkleeft HS; Redinbo MR
    ACS Chem Biol; 2020 Jan; 15(1):217-225. PubMed ID: 31774274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases.
    Biernat KA; Pellock SJ; Bhatt AP; Bivins MM; Walton WG; Tran BNT; Wei L; Snider MC; Cesmat AP; Tripathy A; Erie DA; Redinbo MR
    Sci Rep; 2019 Jan; 9(1):825. PubMed ID: 30696850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbial beta-glucuronidase and glycerol/diol dehydratase activity contribute to dietary heterocyclic amine biotransformation.
    Zhang J; Lacroix C; Wortmann E; Ruscheweyh HJ; Sunagawa S; Sturla SJ; Schwab C
    BMC Microbiol; 2019 May; 19(1):99. PubMed ID: 31096909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut.
    Dashnyam P; Mudududdla R; Hsieh TJ; Lin TC; Lin HY; Chen PY; Hsu CY; Lin CH
    Sci Rep; 2018 Nov; 8(1):16372. PubMed ID: 30401818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.
    Pollet RM; D'Agostino EH; Walton WG; Xu Y; Little MS; Biernat KA; Pellock SJ; Patterson LM; Creekmore BC; Isenberg HN; Bahethi RR; Bhatt AP; Liu J; Gharaibeh RZ; Redinbo MR
    Structure; 2017 Jul; 25(7):967-977.e5. PubMed ID: 28578872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical transformation of xenobiotics by the human gut microbiota.
    Koppel N; Maini Rekdal V; Balskus EP
    Science; 2017 Jun; 356(6344):. PubMed ID: 28642381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbial β-Glucuronidase: A key regulator of endobiotic homeostasis.
    Ning L; Hong J
    Cell Host Microbe; 2024 Jun; 32(6):783-785. PubMed ID: 38870895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives.
    Gloux K; Anba-Mondoloni J
    PLoS One; 2016; 11(1):e0148291. PubMed ID: 26824357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Probe-Enabled Approach for the Selective Isolation and Characterization of Functionally Active Subpopulations in the Gut Microbiome.
    Whidbey C; Sadler NC; Nair RN; Volk RF; DeLeon AJ; Bramer LM; Fansler SJ; Hansen JR; Shukla AK; Jansson JK; Thrall BD; Wright AT
    J Am Chem Soc; 2019 Jan; 141(1):42-47. PubMed ID: 30541282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insights into Endobiotic Reactivation by Human Gut Microbiome-Encoded Sulfatases.
    Ervin SM; Simpson JB; Gibbs ME; Creekmore BC; Lim L; Walton WG; Gharaibeh RZ; Redinbo MR
    Biochemistry; 2020 Oct; 59(40):3939-3950. PubMed ID: 32993284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From homeostasis to pathology: decrypting microbe-host symbiotic signals in the intestinal crypt.
    Pédron T; Nigro G; Sansonetti PJ
    Philos Trans R Soc Lond B Biol Sci; 2016 Nov; 371(1707):. PubMed ID: 27672151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.
    Keane JM; Joyce SA; Gahan CGM; Hyland NP; Houston A
    Results Probl Cell Differ; 2020; 69():581-603. PubMed ID: 33263888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome.
    Gloux K; Berteau O; El Oumami H; Béguet F; Leclerc M; Doré J
    Proc Natl Acad Sci U S A; 2011 Mar; 108 Suppl 1(Suppl 1):4539-46. PubMed ID: 20615998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intestinal environment in health and disease - recent insights on the potential of intestinal bacteria to influence human health.
    Possemiers S; Grootaert C; Vermeiren J; Gross G; Marzorati M; Verstraete W; Van de Wiele T
    Curr Pharm Des; 2009; 15(18):2051-65. PubMed ID: 19519443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.